Vanberra Signal
Free trial

PathomIQ

Curated by Signal

AI-enabled platform for drug development and drug response prediction

Health Technologypathomiq.com

Overview

AI-enabled solution for drug development and drug response prediction. It offers PATHOMIQ_PRAD platform that analyzes digitized H&E radical proctectomy whole slide images using AI platform to produce a report which assesses risk of biochemical relapse and risk of metastasis. It is used to capture the spatio-temporal heterogeneity of the tumor, identify critical spatial interactions of the tumor microenvironment, and predict disease outcome to therapy.

Key facts

Founded
2018
Headquarters
Cupertino, United States
Stage
Sign up to view
Industry
Health Technology

Business model

5 products and services
Sign up to view

Contact

Email
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • Columbia Care

    Online pharmacy for cannabis recreational and medical products

    Health TechnologyDayton, United States

  • Big Ben Medical

    Online platform offering medical supplies and solutions

    Health TechnologyCommerce Township, United States

  • H2OPTX

    Provider of imaging solutions for analyzing the chemical structures in pharmaceuticals

    Health TechnologySan Jose, United States

About PathomIQ

What does PathomIQ do?

AI-enabled solution for drug development and drug response prediction.

Where is PathomIQ headquartered?

PathomIQ is headquartered in Cupertino, United States.

When was PathomIQ founded?

PathomIQ was founded in 2018.

Which sector is PathomIQ in?

PathomIQ operates in Health Technology.

Who are PathomIQ's competitors?

Companies similar to PathomIQ include Columbia Care, Big Ben Medical, and H2OPTX.